pillbase.ru

Cellular Liquescence

Wirkstoff: SAW PALMETTO, ARNICA MONTANA WHOLE, CHOLINE HYDROXIDE, THUJA OCCIDENTALIS LEAFY TWIG, THYMOL, THYMUS SERPYLLUM WHOLE, ARSENIC TRIIODIDE, ASTERIAS RUBENS, BUFO BUFO CUTANEOUS GLAND, HUMAN BREAST TUMOR CELL, ARSENIC TRIBROMIDE, SHARK CARTILAGE, STRYCHNOS WALLICHIANA BARK

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · SAW PALMETTO 3 [hp_X]/mL, ARNICA MONTANA WHOLE 3 [hp_X]/mL, CHOLINE HYDROXIDE 4 [hp_X]/mL, THUJA OCCIDENTALIS LEAFY TWIG 4 [hp_X]/mL, THYMOL 6 [hp_X]/mL, THYMUS SERPYLLUM WHOLE 6 [hp_X]/mL, ARSENIC TRIIODIDE 6 [hp_X]/mL, ASTERIAS RUBENS 12 [hp_X]/mL, BUFO BUFO CUTANEOUS GLAND 12 [hp_X]/mL, HUMAN BREAST TUMOR CELL 16 [hp_X]/mL, ARSENIC TRIBROMIDE 20 [hp_X]/mL, SHARK CARTILAGE 8 [hp_C]/mL, STRYCHNOS WALLICHIANA BARK 9 [hp_C]/mL

Vereinigte StaatenAktiv

Zulassungsinhaber: Nutritional Specialties, Inc.

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • SAW PALMETTO · 3 [hp_X]/mL
  • ARNICA MONTANA WHOLE · 3 [hp_X]/mL
  • CHOLINE HYDROXIDE · 4 [hp_X]/mL
  • THUJA OCCIDENTALIS LEAFY TWIG · 4 [hp_X]/mL
  • THYMOL · 6 [hp_X]/mL
  • THYMUS SERPYLLUM WHOLE · 6 [hp_X]/mL
  • ARSENIC TRIIODIDE · 6 [hp_X]/mL
  • ASTERIAS RUBENS · 12 [hp_X]/mL
  • BUFO BUFO CUTANEOUS GLAND · 12 [hp_X]/mL
  • HUMAN BREAST TUMOR CELL · 16 [hp_X]/mL
  • ARSENIC TRIBROMIDE · 20 [hp_X]/mL
  • SHARK CARTILAGE · 8 [hp_C]/mL
  • STRYCHNOS WALLICHIANA BARK · 9 [hp_C]/mL
Zulassung
Zulassungsnummer
83027-0033
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen